Global Custom Market Research Reports Provider Company

phone

Colon Cancer Global Clinical Trials Review, H1, 2017

  • Published Date: 30 Jun 2017
  • Number of Pages: 603
  • Category: Healthcare and Medical
  • Country: Global
Colon Cancer Global Clinical Trials Review, H1, 2017

Summary

GlobalDatas clinical trial report, Colon Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Colon Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Colon Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Publisher Name : GlobalData
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Colon Cancer Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on Colon Cancer 36
Jun 28, 2017: Mateon Therapeutics Announces New Interim Preclinical Data on CA4P in Combination with Checkpoint Inhibitors 36
Jun 27, 2017: MabVax Therapeutics Commences Patient Dosing in MVT-1075 Radioimmunotherapy Phase 1 Clinical Trial for the Treatment of Pancreatic, Colon and Lung Cancers 36
Jun 22, 2017: Recce constructs automated manufacturing facility to support clinical trials 36
Jun 12, 2017: New cancer drug makes commonly prescribed chemo drug more effective when given together 37
Jun 07, 2017: Spring Bank Provides Update on its Next-Generation STING Platform and Announces Publication of an Abstract at ASCO Related to its Lead STING Agonist Candidate, SB 11285 37
Jun 06, 2017: DEP irinotecan outperforms irinotecan in multiple cancer models 38
May 10, 2017: Loxo Oncology Announces Enrollment of First Patient in Phase 1 Clinical Trial for Highly Selective RET Inhibitor, LOXO-292 39
Apr 07, 2017: Allegheny Health Network Clinical Trial Examines Kinase Inhibitor Regorafenib as Maintenance Therapy for Colon Cancer 39
Clinical Trial Profile Snapshots 40
Appendix 601
Abbreviations 601
Definitions 601
Research Methodology 602
Secondary Research 602
About GlobalData 603
Contact Us 603
Disclaimer 603
Source 603

List Of Tables


Colon Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 8
Colon Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Colon Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Colon Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Colon Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Colon Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
Colon Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
Proportion of Colon Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Colon Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 20
Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
Colon Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 24
Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 25
Colon Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 27
Colon Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28
Colon Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29
Colon Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 30
Colon Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 32
Colon Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 34
Colon Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35

List Of Figures


Colon Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Colon Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Colon Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Colon Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Colon Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Colon Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
Colon Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
Proportion of Colon Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Colon Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 20
Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
Colon Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 24
Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 25
Colon Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
Colon Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28
Colon Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29
Colon Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 30
Colon Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
Colon Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33
Colon Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35
GlobalData Methodology 602

In this report, the EMEA Colony Counters market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing

View Report

In this report, the EMEA Automated Colony Pickers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

View Report

In this report, the global Colon Cancer Rapid Test Kit market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports